Skip to content

Insider · CIK 0001959279

Brian Allen Carrico

ceoofficerdirector

Files at NRXS (Neuraxis, INC). First filing Apr 3, 2026, latest Oct 8, 2026.

In brief

Brian Allen Carrico files SEC Form 4 as CEO and director at NRXS (Neuraxis, INC). Since Apr 3, 2026, Brian Allen Carrico has reported 2 open-market buys worth $17k and 0 open-market sells worth $0, the latest filed on Oct 8, 2026.

A track record needs three past buys with six months of prices behind them; Brian Allen Carrico has 0, so none is measured yet.

The newest scored trade: bought $1,297 of NRXS on Oct 8, 2026, filed Oct 8, 2026, with a score that opens a week after filing. In the last 12 months: 2 buys worth $17k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$17k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NRXS: Neuraxis, INC

NRXSOct 12, 2026 · close 6.72

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
Pro nowfree Oct 15, 2026
NRXSbuy 3
Neuraxis, INC
$1,297
268 shares
+0%-
40Moderate
NRXSbuy 3
Neuraxis, INC
$16k
8,060 shares
+2%+349% from low-6% from high

Transactions

Every row this insider has filed, 11 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 8, 2026NRXS
Neuraxis, INC
POpen-market purchase
Common Stock
+268$4.84$1,297227,6046 d ago
Aug 24, 2026NRXS
Neuraxis, INC
AGrant or award
Common Stock
+199,188--227,336Aug 26, 2026
Aug 24, 2026NRXS
Neuraxis, INC
CConversion
Stock Optionsderivative
-320,000$6.94$2.2M0Aug 26, 2026
Aug 24, 2026NRXS
Neuraxis, INC
AGrant or award
RSUderivative
+320,000--320,000Aug 26, 2026
Aug 24, 2026NRXS
Neuraxis, INC
CConversion
RSUderivative
-320,000--0Aug 26, 2026
Aug 13, 2026NRXS
Neuraxis, INC
AGrant or award
RSUderivative
+193,329$6.28$1.2M193,329Aug 17, 2026
Apr 1, 2026NRXS
Neuraxis, INC
POpen-market purchase
Common Stock
+8,060$1.96$16k348,178Apr 3, 2026
Jan 22, 2026NRXS
Neuraxis, INC
AGrant or award
RSUderivative
+94,173$4.63$436k94,173Feb 26, 2026
Mar 4, 2025NRXS
Neuraxis, INC
AGrant or award
RSUderivative
+10,000$2.18$22k10,000Sep 10, 2025
Mar 4, 2025NRXS
Neuraxis, INC
AGrant or award
RSUderivative
+90,640$2.18$198k90,640Sep 10, 2025
Jan 3, 2025NRXS
Neuraxis, INC
AGrant or award
RSUderivative
+70,019$2.42$169k70,019Sep 10, 2025

Questions about Brian Allen Carrico

Answered from the filings on this page, as of the latest one.

Is Brian Allen Carrico buying or selling?

In the last 12 months Brian Allen Carrico reported 2 open-market buys worth $17k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1,297 of NRXS on Oct 8, 2026. Grants, option exercises and tax withholding are not counted.

How did Brian Allen Carrico's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Allen Carrico has 0.

Where does Brian Allen Carrico file Form 4?

Brian Allen Carrico has filed Form 4 at NRXS (Neuraxis, INC) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Brian Allen Carrico: insider trades and track record | InsiderTell